483
Magna Pharmaceuticals IncMagna Pharmaceuticals Inc – FDA 483, Oct 29, 2021
Record Details
An FDA inspection of Magna Pharmaceuticals Inc. in Louisville, KY, revealed a significant deficiency in their quality system. The firm failed to adequately establish procedures for corrective and preventive actions (CAPA). This indicates a fundamental gap in their ability to address and prevent recurring issues.
- Person
View Company Profile
ID · cd0c0bfe-031e-466e-9898-313ff3fc385e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.